Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-98.91%
operating margin TTM
-107.28%
revenue TTM
162.93 Million
revenue per share TTM
1.88$
valuation ratios | |
|---|---|
| pe ratio | -24.24 |
| peg ratio | -6.94 |
| price to book ratio | 7.08 |
| price to sales ratio | 23.72 |
| enterprise value multiple | -23.25 |
| price fair value | 7.08 |
profitability ratios | |
|---|---|
| gross profit margin | 94.14% |
| operating profit margin | -107.28% |
| pretax profit margin | -98.44% |
| net profit margin | -98.91% |
| return on assets | -21.92% |
| return on equity | -27.67% |
| return on capital employed | -29.65% |
liquidity ratio | |
|---|---|
| current ratio | 4.19 |
| quick ratio | 3.94 |
| cash ratio | 1.09 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 1,407.82 |
| operating cycle | 1,535.69 |
| days of payables outstanding | 1,298.45 |
| cash conversion cycle | 237.24 |
| receivables turnover | 2.85 |
| payables turnover | 0.28 |
| inventory turnover | 0.26 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.06 |
| debt equity ratio | 0.08 |
| long term debt to capitalization | 0.06 |
| total debt to capitalization | 0.07 |
| interest coverage | -27.44 |
| cash flow to debt ratio | -3.33 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.96 |
| cash per share | 3.12 |
| operating cash flow per share | -0.95 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -3.33 |
| short term coverage ratios | -23.33 |
| capital expenditure coverage ratio | -399.01 |
Frequently Asked Questions
When was the last time Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) reported earnings?
Deciphera Pharmaceuticals, Inc. (DCPH) published its most recent earnings results on 10-05-2024.
What is Deciphera Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)'s trailing twelve months ROE is -27.67%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Deciphera Pharmaceuticals, Inc. (DCPH) currently has a ROA of -21.92%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did DCPH's net profit margin stand at?
DCPH reported a profit margin of -98.91% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is DCPH's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.19 in the most recent quarter. The quick ratio stood at 3.94, with a Debt/Eq ratio of 0.08.